Renal and hepatic accumulation of cadmium and lead in the expression of CYP4F2 and CYP2E1

被引:34
作者
Baker, JR
Edwards, RJ
Lasker, JM
Moore, MR
Satarug, S
机构
[1] Univ Queensland, Natl Res Ctr Environm Toxicol, Brisbane, Qld 4108, Australia
[2] Flinders Univ S Australia, Dept Clin Pharmacol, Adelaide, SA, Australia
[3] Univ London Imperial Coll Sci & Technol, Sect Clin Pharmacol, London, England
[4] Hackensack Univ, Inst Biomed Res, Hackensack, NJ USA
[5] QHSS, Brisbane, Qld, Australia
关键词
metal toxins; cadmium; lead; zinc; copper; environmental exposure; CYP2E1; CYP4F2; human liver; human kidney;
D O I
10.1016/j.toxlet.2005.05.016
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The present study examined accumulation of the metal toxins cadmium (Cd) and lead (Pb) in relation to the abundance of cytochrome P450 4F2 (CYP4F2), CYP2E1 and concentrations of zinc and copper in liver and kidney samples using immunoblotting coupled with metal analysis. The post mortem liver and kidney cortex samples were from 23 males and 8 females aged 3-89 years. All were Caucasians who had not been exposed to metals in the workplace. Average kidney cortex Cd load of 17.4 mu g/g w.w. was 17 times greater than average liver Cd load (1.1 mu g/g w.w.). In contrast, average kidney cortex Ph load of 0.09 mu g/g w.w. was two times lower than liver Pb load of 0.19 mu g/g w.w. Average Zn and Cu concentrations in the kidney cortex samples were 67% and 33% lower than those in the liver. Liver and kidney Cd loads, but not liver or kidney Ph loads, correlated positively with donors' age. After controlling for liver Cd load, an inverse correlation was seen between Zn and age (partial r = -0.39, P = 0.02), suggesting reduction in liver Zn levels in old age. Liver CYP2E1 protein abundance correlated with age-adjusted Cd load (partial r = 0.37, P = 0.02) whereas kidney CYP4172 protein abundance showed a positive correlation with age-adjusted Cd loads (partial r = 0.40, P = 0.02). These findings suggest that Cd may be an inducer of renal CYP4172 and hepatic CYP2E1 and that increased renal CYP4172 expression may implicate in Cd-linked renal tubular dysfunction and high blood pressure, involving CYP4F2-dependent arachidonic acid metabolism. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:182 / 191
页数:10
相关论文
共 41 条
[1]   Cytochrome P450 4A and 2E1 expression in human kidney microsomes [J].
Amet, Y ;
Berthou, F ;
Fournier, G ;
Dreano, Y ;
Bardou, L ;
Cledes, J ;
Menez, JF .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (06) :765-771
[2]  
[Anonymous], 1992, CADM ENV HLTH CRIT 1
[3]   Potential for early involvement of CYP isoforms in aspects of human cadmium toxicity [J].
Baker, JR ;
Satarug, S ;
Edwards, RJ ;
Moore, MR ;
Williams, DJ ;
Reilly, PEB .
TOXICOLOGY LETTERS, 2003, 137 (1-2) :85-93
[4]   Associations between human liver and kidney cadmium content and immunochemically detected CYP4A11 apoprotein [J].
Baker, JR ;
Satarug, S ;
Urbenjapol, S ;
Edwards, RJ ;
Williams, DJ ;
Moore, MR ;
Reilly, PEB .
BIOCHEMICAL PHARMACOLOGY, 2002, 63 (04) :693-696
[5]   Relationships between non-occupational cadmium exposure and expression of nine cytochrome P450 forms in human liver and kidney cortex samples [J].
Baker, JR ;
Satarug, S ;
Reilly, PEB ;
Edwards, RJ ;
Ariyoshi, N ;
Kamataki, T ;
Moore, MR ;
Williams, DJ .
BIOCHEMICAL PHARMACOLOGY, 2001, 62 (06) :713-721
[6]   Cardiovascular pathophysiology of environmental pollutants [J].
Bhatnagar, A .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (02) :H479-H485
[7]   Eicosanoids in cirrhosis and portal hypertension [J].
Birney, Y ;
Redmond, EM ;
Sitzmann, JV ;
Cahill, PA .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2003, 72 (1-2) :3-18
[8]   Oxidative stress, toxicology, and pharmacology of CYP2E1 [J].
Caro, AA ;
Cederbaum, AI .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 :27-42
[9]   Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension - The Normative Aging Study [J].
Cheng, YW ;
Schwartz, J ;
Sparrow, D ;
Aro, A ;
Weiss, ST ;
Hu, H .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (02) :164-171
[10]   Development of a comprehensive panel of antibodies against the major xenobiotic metabolising forms of cytochrome P450 in humans [J].
Edwards, RJ ;
Adams, DA ;
Watts, PS ;
Davies, DS ;
Boobis, AR .
BIOCHEMICAL PHARMACOLOGY, 1998, 56 (03) :377-387